Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats, Yuki Hirakawa, Mutsumi Tsuchishima, Atsushi Fukumura, Kaori Kinoshita, Nobuhiko Hayashi, Takashi Saito, Joseph George, Toshikuni Nobuyuki, Ueda Yoshimichi, Tsutsumi Mikihiro, European Journal of Pharmacology, 863:172681, Dec. 2019
The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people, Kaori Kinoshita, Nobuyuki Toshikuni, Takashi Saito, Nobuhiko Hayashi, Takahiro Minato, Yasuhiro Matsue, Yoshimichi Ueda, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Turkish Journal of Medical Scences, 49:1350-1357, Oct. 2019
An image fusion system for estimating the therapeutic effects of radiofrequency ablation on hepatocellular carcinoma, Toshikuni, Nobuyuki;Matsue, Yasuhiro;Ozaki, Kazuaki;Yamada, Kaho;Hayashi, Nobuhiko;Tsuchishima, Mutsumi;Tsutsumi, Mikihiro, RADIOLOGY AND ONCOLOGY, 51:263-269, Sep. 2017
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis, Toshikuni, Nobuyuki, GUT AND LIVER, 11:335-348, May 2017
Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis, Toshikuni, Nobuyuki;Tsuchishima, Mutsumi;Fukumura, Atsushi;Arisawa, Tomiyasu;Tsutsumi, Mikihiro, GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017:9127847, 2017
Management of gastroesophageal varices in cirrhotic patients: current status and future directions., N.Toshikuni, Y.Takuma, M.Tsutsumi, Annals of hepatology, 15:314-325, May 2016
GGsTop, a novel and specific γ-glutamyl transpeptidase inhibitor, protects hepatic ischemia-reperfusion injury in rats., K.Tamura, N.Hayashi, J.George, M.Toshikuni, T.Arisawa, J.Hiratake, M.Tsuchishima, M.Tsutsumi, American journal of physiology. Gastrointestinal and liver physiology, 311:Ｇ305-Ｇ312, 2016
Elevated serum gamma-glutamyl transpeptidase levels and fatty liver strongly predict the presence of carotid plaque, N.Toshikuni,T.Asaji,Y.Nakanishi,SY.Nagasawa,H.Uenishi,M.Tsutsumi, Journal of Atherosclerosis and Thrombosis, 22:1051-1060, Feb. 2015
Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus Infection, Y.Matsue, M.Tsutsumi, N.Hayashi, T.Saito, M.Tsuchishima, N.Toshikuni, T.Arisawa, J.George, PLoS One, 10:e0118744-e0118744, 2015
Serum endocan as a survival predictor for patients with liver cirrhosis, N.Toshikuni, K.Ozaki, J.George, M.Tsutsumi, Canadian Journal of Gastroenterology and Hepatology, 29:427-430, 2015
Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease, N.Toshikuni, M.Tsutsumi, T.Arisawa, World journal of gastroenterology : WJG., 20:8393-8406, Jul. 2014
Nutrition and exercise in the management of liver cirrhosis, N.Toshikuni, T.Arisawa, M.Tsutsumi, World journal of gastroenterology : WJG., 20:7286-7297, Jun. 2014
Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation,hepatocarcinogenesis,and mortality, N.Toshikuni, T.Arisawa, M.Tsutsumi, World journal of gastroenterology : WJG., 20:2876-2887, Mar. 2014
The *1244A>G polymorphism of MyD88(rs7744)is closely associated with susceptibility to ulcerative colitis, K.Matsunaga, T.Tahara, H.Shiroeda, T.Otsuka, M.Nakamura, T.Shimasaki, N.Toshikuni, N.Kawada, T.Shibata, T.Arisawa, Molecular medicine reports., 9:28-32, Jan. 2014
Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma, K.Ozaki, N.Toshikuni, J.George, T.Minato, Y.Matsue, T.Arisawa, M.Tsutsumi, Journal of Cancer [electronic resource], 5:221-230, 2014
Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma., N.Toshikuni, M.Tsutsumi, Y.takuma, T.Arisawa, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine., 33:2005-2010, 2014
Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-lnduced simple steatosis, T.Minato, M.Tsutsumi, M.Tsuchishima, N.Hayashi, T.Saito, Y.Matsue, N.Toshikuni, T.Arisawa, J.George, Molecular medicine (Cambridge, Mass.), 20:490-502, 2014
Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease., N.Hayashi, J.George, M.Takeuchi, A.Fukumura, N.Toshikuni, T.Arisawa, M.Tsutsumi, PloS one, 8:e70034;1-14, Jul. 2013
Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study., N.Hayashi, J.George, H.Shiroeda, T.Saito, N.Toshikuni, M.Tsuchishima, T.Arisawa, M.Tsutsumi, Journal of gastroenterology and hepatology., 28:1015-1018, Jun. 2013
Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension,diabetes mellitus,and dyslipidemia., N.Toshikuni, A.Fukumura, N.Hayashi, T.Nomura, M.Tsuchishima, T.Arisawa, M.Tsutsumi, Journal of clinical biochemistry and nutrition, 52:82-88, Jan. 2013
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium., T.Nomura, T.Tahara, H.Shiroeda, T.Minato, Y.Matsue, R.Hayashi, K.Matsunaga, T.Otsuka, M.Nakamura, N.Toshikuni, T.Shibata, T.Arisawa, BMC gastroenterology, 13:1471-1479, 2013
Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer., T.Arisawa, T.Tahara, H.Shiroeda, K.Yamada, T.Nomura, H.Yamada, R.Hayashi, K.Matsunaga, T.Otsuka, M.Nakamura, T.Shimasaki, N.Toshikuni, N.Kawada, T.Shibata, Oncology reports., 30:3013-3019, 2013
Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma., N.Toshikuni, H.Shiroeda, K.Ozaki, Y.Matsue, T.Minato, T.Nomura, N.Hayashi, T.Arisawa, M.Tsutsumi, Radiology and oncology., 47:224-229, 2013
Sonazoid‑enhanced ultrasound images of multiacinar cirrhotic
nodules showing a “donut‑like” hyperintense appearance
on Gd‑EOB‑MRI: a case report, Ryuichi Kubota, Nobuyuki Toshikuni, Mikihiro Tsutsumi, Mutsumi Tsuchishima, Journal of Medical Ultrasonics, https://doi.org/10.1007/s10396-023-01353-4:https://doi.org/10.1007/s10396-023-01353-4, Aug. 2023
Albumin-bilirubin score as a marker for predicting occurence of hepatocellular carcinoma in patients with liver cirrhosis, 82:5925, Jun. 2022
